Fentiazac 5% cream was applied topically on limited articular and extraarticular inflammatory lesions in the course of a double-blind clinical trial versus placebo.
The drug proved to be satisfactorily tolerated and also therapeutically effective since it changed significantly (p < 0.05 — < 0.01) the spontaneous course of the microtraumatic pathologic pattern producing an early attenuation and resolution of the painful and functional symptomatic pattern.
Get full access to this article
View all access options for this article.
References
1.
BcrnardezD CacheroLopezV ConcejeroMorenillaJ M Abad (1980) Studio clinico con un antiinnammatorio topico in campo traumatologico. Giornale Italiano di Ricerche Cliniche e Terapeutiche1, 164.
2.
FelletA JLeitaoA CFernandesC F (1980) Efeito percutaneo do Fentiazac em reumatismo nao articular (Abstract). Revista Brasileira de Reumatologia20, 3.
3.
FraccaroliJ LLuzWDa CostaA (1980) Aplicaçao do ‘Atilan’ pomada em lesoes traumato-desportivas. Revista Brasileira de Medicina37, 4.
4.
VazA Lopes (1980) Double-blind clinical trial with Fentiazac in rheumatic patients. Jornal do MedicoXL, 114.
5.
ZanoloGGiacchettiCMondinoASilvestriSDe MarchiGGomarascaP (1980) Azione topica di Fentiazac: assorbimento per via epicutanea. Bollettino Chimico Farmaceutico119, 209.
